ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN

被引:191
|
作者
ALBINI, A
BARILLARI, G
BENELLI, R
GALLO, RC
ENSOLI, B
机构
[1] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
[2] IST NAZL RIC CANC,I-16132 GENOA,ITALY
关键词
AIDS; KAPOSI SARCOMA; ANGIOGENESIS; VASCULAR CELL INVASION; MORPHOGENESIS;
D O I
10.1073/pnas.92.11.4838
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Extracellular human immunodeficiency virus type 1 (HIV-1) Tat protein promotes growth of spindle cells derived from AIDS-associated Kaposi sarcoma (AIDS-KS), an angioproliferative disease very frequent in HIV-1-infected individuals. Normal vascular cells, progenitors of AIDS-KS cells, proliferate in response to Tat after exposure to inflammatory cytokines, whose levels are augmented in HIV-l-infected individuals and in KS lesions. Here we show that Tat also promotes AIDS-KS and normal vascular cells to migrate and to degrade the basement membrane and stimulates endothelial cell morphogenesis on a matrix substrate. These effects are obtained at picomolar concentrations of exogenous Tat and are promoted by the treatment of the cells with the same inflammatory cytokines stimulating expression of the receptors for Tat, the integrins alpha(5) beta(1) and alpha(v) beta(3). Thus, under specific circumstances, Tat has angiogenic properties. As Tat and its receptors are present in AIDS-KS lesions, these data may explain some of the mechanisms by which Tat can induce angiogenesis and cooperate in the development of AIDS-KS.
引用
收藏
页码:4838 / 4842
页数:5
相关论文
共 50 条
  • [1] THE TAT GENE AND PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CAPUTO, A
    GROSSI, MP
    ROSSI, C
    CAMPIONI, D
    BALBONI, PG
    CORALLINI, A
    BARBANTIBRODANO, G
    MICROBIOLOGICA, 1995, 18 (01): : 87 - 110
  • [2] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [4] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CYTOMEGALOVIRUS IN SALIVA
    LUCHT, E
    ALBERT, J
    LINDE, A
    XU, WM
    BRYTTING, M
    LUNDEBERG, J
    UHLEN, M
    BRATT, G
    SANDSTROM, E
    HEIMDAHL, A
    NORD, CE
    WAHREN, B
    JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) : 156 - 162
  • [5] HEADACHE AND THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    HOLLOWAY, RG
    KIEBURTZ, KD
    HEADACHE, 1995, 35 (05): : 245 - 255
  • [6] INTEGRATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA INVITRO
    FARNET, CM
    HASELTINE, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) : 4164 - 4168
  • [7] MOLECULAR-BIOLOGY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HASELTINE, WA
    FASEB JOURNAL, 1991, 5 (10) : 2349 - 2360
  • [8] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF NEURAL XENOGRAFTS
    CVETKOVICH, TA
    LAZAR, E
    BLUMBERG, BM
    SAITO, Y
    ESKIN, TA
    REICHMAN, R
    BARAM, DA
    DELCERRO, C
    GENDELMAN, HE
    DELCERRO, M
    EPSTEIN, LG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 5162 - 5166
  • [9] OLTIPRAZ, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    PROCHASKA, HJ
    YEH, Y
    BARON, P
    POLSKY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3953 - 3957
  • [10] RELATIONSHIP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEQUENCE HETEROGENEITY TO STAGE OF DISEASE
    MCNEARNEY, T
    HORNICKOVA, Z
    MARKHAM, R
    BIRDWELL, A
    ARENS, M
    SAAH, A
    RATNER, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10247 - 10251